Diffuse Large B-Cell Lymphoma: Treatment Beyond R-CHOP
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Interpret the findings from clinical trials on the use of novel therapeutic strategies and how these strategies can be incorporated into current treatment paradigms
Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- 0.50 Participation
- 0.50 Nurse
- 0.50 Pharmacist
- 0.50 Physician